{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T09:05:31Z","timestamp":1766048731981},"reference-count":37,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,23]],"date-time":"2016-09-23T00:00:00Z","timestamp":1474588800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.clinthera.2016.09.005","type":"journal-article","created":{"date-parts":[[2016,10,15]],"date-time":"2016-10-15T20:53:09Z","timestamp":1476564789000},"page":"2171-2184","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study"],"prefix":"10.1016","volume":"38","author":[{"given":"Sang-Hyun","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Ho","family":"Jo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Cheol","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Yoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Ho","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyang-Lim","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nae-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong-Won","family":"Ha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong-Woon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu-Rok","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min-Su","family":"Hyon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deok-Gyu","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Gyu","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Dae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu-Hyung","family":"Ryu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheol-Ho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kee-Sik","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myung-Ho","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Chul","family":"Chae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Bae","family":"Seung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byung-Hee","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2016.09.005_bib1","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/HJH.0000000000000253","article-title":"Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence","volume":"32","author":"Zanchetti","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2016.09.005_bib2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1097\/HJH.0b013e3283619d6a","article-title":"Simplified therapeutic intervention to control hypertension and hypercholesterolemia: a cluster randomized controlled trial (STITCH2)","volume":"31","author":"Dresser","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.clinthera.2016.09.005_bib3","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/2047487315569401","article-title":"EUROASPIRE IV: a European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries","volume":"23","author":"Kotseva","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.clinthera.2016.09.005_bib4","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1161\/HYPERTENSIONAHA.114.04639","article-title":"Combined effect of blood pressure and total cholesterol levels on long-term risks of subtypes of cardiovascular death: evidence for Cardiovascular Prevention from Observational Cohorts in Japan","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2016.09.005_bib5","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence-based guideline for the management of high blood pressure in adults report from the panel members appointed by the Eighth Joint National Committee","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"25 pt B","key":"10.1016\/j.clinthera.2016.09.005_bib6","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2016.09.005_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2147\/IBPC.S12215","article-title":"Combining antihypertensive and antihyperlipidemic agents\u2014optimizing cardiovascular risk factor management","volume":"4","author":"Zamorano","year":"2011","journal-title":"Integr Blood Pressure Control"},{"key":"10.1016\/j.clinthera.2016.09.005_bib8","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7326\/0003-4819-148-1-200801010-00189","article-title":"Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension","volume":"148","author":"Matchar","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2016.09.005_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jash.2015.11.005","article-title":"Cardiovascular and cerebrovascular outcomes of long-term angiotensin receptor blockade: meta-analyses of trials in essential hypertension","volume":"10","author":"Akioyamen","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.clinthera.2016.09.005_bib10","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1751-7176.2011.00518.x","article-title":"Angiotensin receptor blockers: pharmacology, efficacy, and safety","volume":"13","author":"Taylor","year":"2011","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.clinthera.2016.09.005_bib11","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/HYPERTENSIONAHA.112.199562","article-title":"Ambulatory blood pressure values in the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial (ONTARGET)","volume":"60","author":"Mancia","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.clinthera.2016.09.005_bib12","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Cholesterol Treatment","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2016.09.005_bib13","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2016.09.005_bib14","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehr333","article-title":"The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the U.K","volume":"32","author":"Sever","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2016.09.005_bib15","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2016.09.005_bib16","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1161\/CIRCULATIONAHA.109.904003","article-title":"Medication adherence in cardiovascular disease","volume":"121","author":"Baroletti","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2016.09.005_bib17","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.clinthera.2016.09.005_bib18","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1524-6175.2005.04533.x","article-title":"Single-pill therapy in the treatment of concomitant hypertension and dyslipidemia (the Amlodipine\/Atorvastatin Gemini study)","volume":"7","author":"Blank","year":"2005","journal-title":"J Clin Hypertens"},{"key":"10.1016\/j.clinthera.2016.09.005_bib19","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCULATIONAHA.108.830299","article-title":"Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients","volume":"120","author":"Mazzaglia","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2016.09.005_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ahj.2013.09.014","article-title":"Untangling the relationship between medication adherence and post-myocardial infarction outcomes: medication adherence and clinical outcomes","volume":"167","author":"Choudhry","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/j.clinthera.2016.09.005_bib21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1161\/CIRCULATIONAHA.105.505636","article-title":"Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease","volume":"113","author":"Newby","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2016.09.005_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1136\/bmj.326.7404.1419","article-title":"A strategy to reduce cardiovascular disease by more than 80%","volume":"326","author":"Wald","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2016.09.005_bib23","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(09)60611-5","article-title":"Effects of a polypill (Polycap) on risk factors in middle-aged individuals without cardiovascular disease (TIPS): a phase II, double-blind, randomised trial","volume":"373","author":"Indian Polycap","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2016.09.005_bib24","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1111\/j.1742-1241.2010.02412.x","article-title":"A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy (\u05f3polypill\u05f3) on cardiovascular risk factors","volume":"64","author":"Malekzadeh","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.clinthera.2016.09.005_bib25","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1093\/eurheartj\/ehi841","article-title":"Benefits, challenges, and registerability of the polypill","volume":"27","author":"Sleight","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2016.09.005_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/11532170-000000000-00000","article-title":"Preservation of bioavailability of ingredients and lack of drug-drug interactions in a novel five-ingredient polypill (polycap): a five-arm phase I crossover trial in healthy volunteers","volume":"10","author":"Patel","year":"2010","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.clinthera.2016.09.005_bib27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/jhh.2008.114","article-title":"Single-pill amlodipine\/atorvastatin helps patients of diverse ethnicity attain recommended goals for blood pressure and lipids (the Gemini-AALA study)","volume":"23","author":"Erdine","year":"2009","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.clinthera.2016.09.005_bib28","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4065\/83.1.35","article-title":"Improved attainment of blood pressure and cholesterol goals using single-pill amlodipine\/atorvastatin in African Americans: the CAPABLE trial","volume":"83","author":"Flack","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clinthera.2016.09.005_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ijcard.2005.10.017","volume":"110","author":"Hobbs","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2016.09.005_bib30","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1185\/03007995.2011.555754","article-title":"Proactive multiple cardiovascular risk factor management compared with usual care in patients with hypertension and additional risk factors: the CRUCIAL trial","volume":"27","author":"Zamorano","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2016.09.005_bib31","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4070\/kcj.2015.45.3.225","article-title":"Additive beneficial effects of valsartan combined with rosuvastatin in the treatment of hypercholesterolemic hypertensive patients","volume":"45","author":"Jang","year":"2015","journal-title":"Korean Circ J"},{"key":"10.1016\/j.clinthera.2016.09.005_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.clinthera.2016.09.005_bib33","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/B:REMD.0000032414.17672.5c","article-title":"Inflammation in atherosclerosis and diabetes mellitus","volume":"5","author":"Plutzky","year":"2004","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/j.clinthera.2016.09.005_bib34","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000165070.46111.9F","article-title":"Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress, and inflammation in type 2 diabetic patients","volume":"111","author":"Ceriello","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2016.09.005_bib35","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2337\/dc11-0324","article-title":"Initial angiotensin receptor blockade-induced decrease in albuminuria is associated with long-term renal outcome in type 2 diabetic patients with microalbuminuria: a post hoc analysis of the IRMA-2 trial.","volume":"34","author":"Hellemons","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clinthera.2016.09.005_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2016.09.005_bib37","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291816307275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T16:24:07Z","timestamp":1536337447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291816307275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0149291816307275"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.09.005","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III Study","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2016.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}